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Abstract TRPA1 is activated by electrophilic compounds
such as mustard oil (MO). Here, we demonstrate a bimodal
sensitivity of TRPA1 to ligustilide (Lig), an electrophilic
volatile dihydrophthalide of dietary and medicinal rele-
vance. Lig is a potent TRPA1 activator and is also capable
to induce a modest block of MO activated currents.
Aromatization to dehydroligustilide (DH-Lig), as occurs
during aging of its botanical sources, reversed this profile,
enhancing TRPA1 inhibition and reducing activation.
Mutation of the reactive cysteines in mouseTRPA1
(C622S, C642S, C666S) dramatically reduced activation
by MO and significantly reduced that by Lig, but had an
almost negligible effect on the action of DH-Lig, whose
activation mechanism of TRPA1 is therefore largely
independent from the alkylation of cysteine residues. Taken
together, these observations show that the phthalide
structural motif is a versatile platform to investigate the
modulation of TRPA1 by small molecules, being tunable in
terms of activation/inhibition profile and mechanism of
interaction. Finally, the action of Lig on TRPA1 may
contribute to the gustatory effects of celery, its major
dietary source, and to the pharmacological action of
important plants from the Chinese and native American
traditional medicines.
Keywords TRP channels . TRPA1 . Chemosensation .
Electrophiles .Mustard oil . Traditional Chinese medicine
Introduction
TRPA1 is robustly activated by the pungent constituents of
mustard oil (MO), cinnamon and garlic, and mediates the
inflammatory actions of environmental irritants and proal-
gesic agents, paradoxically mediating also their analgesic
responses. Ligustilide (Lig) is a major constituent of the
aroma of celery (Apium graveolens L.) [23] and lovage
(Levisticum officinale L.) [7], and is contained in high
concentrations in popular medicinal plants from the folk
medicine of China [dong-quai (Angelica sinensis (Oliv.)
Dill.) [12], chuanxiong (Ligusticum chuanxiong Hort.)
[15]] and North America (oshá, Ligusticum portieri Coult.
& Rose) [15] (Fig. 1). Given the dietary and the medicinal
relevance of Lig, its biological activity has been extensively
investigated, evidencing a remarkably pleiotropic profile,
that involves vasodilatation [4], a decrease of platelet
aggregation [27], analgesic effects [6], attenuation of
lipopolysaccharide (LPS)-induced proinflammatory re-
sponse and endotoxic shock [21, 24], neuroprotection
[25], and anti-proliferation of smooth muscle cells [13].
Of special interest is the remarkably fast brain bioavailabil-
ity of Lig by nasal administration, with detectable cerebral
concentrations within 20 min after nasal exposure [8, 9], an
interesting observation because the biological profile of Lig
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has several potential applications in the realm of brain
diseases [18, 25]. Despite this burgeoning biomedical
literature, very little is known on the molecular target(s)
of Lig. Lig is a reactive compound, easily aromatized to
dehydroligustilide (DH-Lig) by air oxidation [20], and
capable to trap thiol groups in a complex, multiple, and
reversible fashion [3]. The unique electrophilic behavior of
Lig, its dietary relevance, and its potential clinical relevance
for various realms of neurosciences [18, 25], provided a
rationale for investigating its action on TRPA1, an ion
channel that, due to its expression in the oral and nasal
cavity and its sensitivity to electrophiles, might represent a
target for this compound [22]. In this work, we demonstrate
that Lig is a potent activator of TRPA1 with only a modest
inhibitory activity, that this profile of activity is reversed by
aromatization to DH-Lig, a potent blocker of MO-activated
currents, and that these compounds, despite their structural




We used a tetracycline-regulated system for inducible
expression of mouse TRPA1 in CHO cells. To induce
expression of TRPA1, 0.5 μg/ml tetracycline was added to
the culture medium, and cells were used 2–3 h after
induction [22]. In some experiments, naive CHO cells were
transiently transfected with TRPA1 mutant clones in the
bicistronic pCAGGS-IRES-GFP vector using TransIT-293
transfection reagent (Mirus). Mutations in TRPA1 were
introduced using the QuickChangeTM Site-Directed Muta-
genesis Kit (Stratagene). The nucleotide sequences of the
mutants were verified by sequence analysis of the
corresponding cDNAs.
Electrophysiology
For electrophysiological recordings in the whole-cell mode
of the patch-clamp technique, CHO cells were maintained
in an extracellular recording solution containing (in mM)
150 NaCl, 5 MgCl2, 10 Glucose, and 10 N-(hydroxyethyl)
piperazine-N′-2-ethanesulfonic acid (HEPES), buffered at
pH 7.4 with NaOH. The intracellular standard pipette
solution contained (in mM): 100 aspartic acid, 40 KCl, 5
EGTA, 4 ATP, 2 MgCl2, 1.2 CaCl2, and 10 HEPES, buffered
at pH 7.2 with KOH. Patch-clamp electrodes were pulled
from Vitrex capillary tubes (Modulohm, Herlev, Denmark)
on a DMZ-Universal puller (Zeitz Instruments, Augsburg,
Germany). When filled with pipette solution, they showed a
DC resistance between 3 and 5 MΩ for whole-cell
recording. An Ag-AgCl wire was used as reference electrode.
Ag-AgCl electrodes of sintered pellets (IVM Systems,
Healdsburg, CA, USA) were used to avoid contamination
of the bath and pipette solutions. Membrane currents
were recorded using an EPC-10 patch-clamp amplifier
(List Electronic, Lambrecht/Pfalz, Germany). For control
of voltage-clamp protocols and data acquisition, we used
the PATCHMASTER software (HEKA Elektronik, Ger-
many) run on an IBM-compatible PC. For whole-cell
analysis, data were recorded at 5 kHz and filtered at
2.9 kHz with PATCHMASTER software. The cell
capacitance and series resistance were assessed using
the analog compensation circuit of the EPC-10 amplifier.
Generally, between 50% and 80% of the series resistance was
electronically compensated to minimize voltage errors.
Experiments were performed at room temperature (20–25°C).
Reagents
Mustard oil (allyl isothiocyanate [AITC], MO) was pre-
pared from ethanol based 100 mM stock solutions that were
kept for not longer than 1 month at −20°C. Otherwise, fresh
dilutions (1 mM−10 mM in test solutions) were prepared
daily from a 10 M MO stock that was kept at 4°C. All
products were purchased from Sigma (Bornem, Belgium).
Lig and DH-Lig were isolated from the essential oil of L.
chuanxiong Hort. by gravity column chromatography [8].
All compounds were added from these stock solutions to
the extracellular recording solution. The final ethanol
concentration in recording solutions was less than 0.1%.
In situ trapping experiments with cysteamine were carried
out in DMSO-d6, reacting Lig and DH-Lig with a two-fold
excess of cysteamine [2].
Data analysis
Statistical analysis and graphical presentations were per-
formed using the Origin ver. 7.0 software (OriginLab,
Northampton, MA, USA). Significance was tested with
analysis of variance (ANOVA) and Student’s unpaired t-test.
All data are presented as mean ± SEM.
Results
Ligustilide and dehydroligustilide activate TRPA1
The dihydrophthalide ligustilide (Z-3-butylidene-4,5-dihy-
droisodenzofuranone, Lig) and its aromatized analogue
dehydroligusitilide (DH-Lig) (Fig. 1a, b) were isolated
from the essential oil of chuanxiong (Ligusticum chuan-
xiong Hort.), and were extracellularly applied to test their
effects on TRPA1 modulation.
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We performed whole-cell patch-clamp recordings in
CHO cells expressing the mouse isoform of TRPA1.
Consistent with previous reports, repetitive application of
a voltage ramp from −100 to +100 mV from a holding
potential of 0 mV elicited sizable TRPA1 currents, indica-
tive of constitutively open TRPA1 channels [11, 17].
Extracellular application of Lig and DH-Lig induced a fast
activation of both outward and inward currents (Fig. 2a, c).
Washout of 300 μM Lig did not result in a rebound
activation, whereas washout of DH-Lig consistently in-
duced a rapid increase of TRPA1 currents (off-response)
followed by a slow recovery (Fig. 2c). Current voltage
relationships of the activated currents are shown in Fig. 2b
and d. The activated currents show an almost linear I–V
relationship which is typical for MO activated TRPA1
currents.
Measurements of dose response curves for Lig and DH-
Lig resulted EC50 values of 44 and 539 μM for Lig and
DH-Lig, respectively (n=4, Fig. 2e). If 100 μM MO was
applied, additional application of Lig did only induce small
changes in the activated current (Fig. 2a), whereas — as
expected from the washout off response — application of
DH-Lig induced a striking current inhibition (Fig. 2c). This
result suggested that lower concentrations of DH-Lig have
an agonistic effect on TRPA1, a transient current increase
upon washout being observed. Nevertheless, when applied
to cells in which TRPA1 is pre-activated by MO applica-
tion, DH-Lig causes marked inhibitory effects.
Potent block of TRPA1 by dehydroligustilide
To investigate this effect in more detail (Fig. 3), TRPA1 was
activated with 100 μM MO. Application of Lig only
induced a shallow block of the current at very high
concentrations (Fig. 3a), while application of 1 mM
induced an average of less than 50% block of TRPA1 in
both inward and outward direction. The I–V curves clearly
show that its effect is not voltage dependent (Fig. 3b). In
comparison, application of DH-Lig causes already at
100 μM a nearly complete block of the TRPA1 mediated
current, which is again voltage independent (Fig. 3c and d).
Inhibition of the MO-induced current was calculated by
Inh %ð Þ ¼ Ipre  Itest
Ipre
 100
where Inh is the blocking effect in %, Ipre is the MO-
activated current immediately before Lig/DH-Lig applica-
Fig. 1 Chemical structures of ligustilide and dehydroligustilide
originated from Angelica sinensis and Ligusticum chuanxiong Hort.
a Chemical structure of ligustilide (Lig). b Chemical structure of
dehydroligustilide (DH-Lig), a degradation product of Lig. The
differences of Lig and DH-Lig are shown (box), the location of the
electrophilic and the nucleophilic sites. Note that there is a more
extended nature of their reactive moiety as compared to classic TRPA1
activators like acrolein. c Angelica sinensis and its root, radix Angelica
sinensis. d Ligusticum chuanxiong Hort. and its root, Rhizoma
chuanxiong (plant figures with permission from Shandong University
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tion, Itest is the minimal current during application of the
both compounds. DH-Lig has a much higher blocking
efficiency than Lig. The IC50 values for Lig and DH-Lig
were 1,456 and 23 μM, respectively (n=6, Fig. 3e).
Cross-desensitization between MO and ligustilide/
dehydroligustilide
We next tested a possible cross-desensitization to activation of
TRPA1 by MO. Application of MO does not allow a second
TRPA1 activation, a phenomenon known as desensitization.
We tested whether this phenomenon is also present for TRPA1
activation by Lig and DH-Lig. In these experiments, we used
solutions with an extracellular Ca2+ concentration of 1.5 mM
to accelerate TRPA1 inactivation [17]. Figure 4 shows a
representative example (n=5). Application of 300 μM Lig
resulted in a fast TRPA1 activation with nearly identical
inward and outward currents. Washout of Lig caused a
current decrease. If 100 μM MO was applied after Lig
stimulation, no current was activated (Fig. 4a). Conversely,
an application of 100 μM MO resulted in TRPA1 current
activation, and no subsequent stimulation by Lig could be
observed (Fig. 4b), as expected by a cross-desensitization
between MO and Lig. Application of 300 μM DH-Lig
resulted in a smaller but transient activation of TRPA1. After
washing out of DH-Lig, a dramatic rebound effect could be
always observed, strongly suggesting an off-response reac-
tion from TRPA1 inhibition by DH-Lig. Application of MO
after this first DH-Lig stimulation failed in any current
activation (Fig. 4c). Vice versa, an initial stimulation of
TRPA1 by MO prevented a secondary stimulation by DH-
Lig. However, DH-Lig inhibited the probably still partially
activated TRPA1 current (Fig. 4d). Both compounds there-
fore caused cross-desensitization with MO.
Fig. 2 Effects of ligustilide and dehydroligustilide on whole-cell
currents through TRPA1. a Time course of whole-cell currents through
TRPA1 measured at membrane potential of −80 mV (black squares)
and +80 mV (red circles) during application of Lig and MO at
indicated concentrations. Note the fast activation of both outward and
inward currents by Lig. b Current–voltage (I–V) relationships obtained
with voltage ramps from −100 to +100 mV at the times indicated in a.
c Current traces of TRPA1-expressing CHO cells at membrane
potential of −80 mV (black squares) and +80 mV (red circles) during
application of DH-Lig and MO at indicated concentrations. Note the
rapid rebound activation after washout of 300 μM DH-Lig and the
striking current inhibition of DH-Lig on TRPA1 pre-activated by 100 μM
MO. d I–V relationships obtained with voltage ramps from −100
to +100 mV at the times indicated in c. e Dose–response curves of Lig
and DH-Lig on the activation of TRPA1. EC50 values of Lig and DH-
Lig varied greatly, which were 44 and 539 μM, respectively
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Differential activation of TRPA1 by ligustilide
and dehydroligustilide
To investigate the mechanism of Lig and DH-Lig action on
TRPA1 gating in more detail, we used TRPA1 mutations in
which three of the most reactive cysteines were exchanged
by non-reactive serines [10]. Figure 5a shows that applica-
tion of 300 μM Lig still activated TRPA1 (see calibration),
but to a lesser extent than for the wild-type clone.
Stimulation by MO was small and extremely delayed.
Application of Lig after MO still resulted in a similar
“activation” pattern as for the non-mutant channel. I–V
curves are again linear in the negative voltage range but
show the very variable inactivation at positive potentials
[22]. The increase in current after agonist activation is
significantly reduced for both Lig and MO in the here
shown C622/642S mutant (Fig. 5c, n=5). In contrast,
application of DH-Lig to the double mutant resulted in a
nearly unchanged activation pattern. After DH-Lig wash-
out, a rebound effect was still measureable, and DH-Lig
could also induce the TRPA1 block described above
(Fig. 5d–f). In this series (n=5), mutation of the two
reactive cysteines resulted in a significant diminution of the
MO activated TRPA1 current (Fig. 5d). Obviously, Lig
activation of TRPA1 depends much more on the reactive
cysteines than on activation by DH-Lig.
We also tested the single (C622S) and triple (C622/642/
666S) mutants. The pattern measured with the double
mutant (C622/642S) mutation was confirmed. Both, the Lig
and the MO response were significantly reduced in the all
cysteine mutants (Fig. 6a). However, the DH-Lig response
was not significantly affected, and also in the same series,
the MO effect was highly significantly inhibited (Fig. 6b;
all n=5 and measured at +80 mV). Thus, MO and Lig
require at least part of the so far described mouseTRPA1
reactive cysteines, whereas DH-Lig does not require these
residues, showing differences in the mode of TRPA1
activation by both compounds.
In addition, we measured effects of Lig and DH-Lig on
mouseTRPV1. Both compounds only show a nearly
Fig. 3 Differential block effects of ligustilide and dehydroligustilide
on whole cell currents through TRPA1. a Time course of whole-cell
currents through TRPA1 activated with 100 μM MO, followed by a
shallow block of 1 mM Lig measured at membrane potential
of −80 mV (black circles) and +80 mV (red circles). b I–V
relationships obtained with voltage ramps from −100 to +100 mV at
the times indicated in a. c Time course of whole-cell currents through
TRPA1 activated with 100 μM MO, followed by a nearly complete
block of 100 μM DH-Lig measured at membrane potential of −80 mV
(black circles) and +80 mV (red circles). d I–V relationships with
voltage ramps from −100 to +100 mV measured at the times shown in
c. e Dose–response curves for the inhibition on MO-induced currents
by Lig and DH-Lig. The IC50 values for Lig and DH-Lig were 1,456
and 23 μM, respectively
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negligible activation of TRPV1 (7.2±2% and 6.8±3% for
300 μM Lig and DH-Lig, respectively, as compared with
0.1 μM capsaicin, +80 mV, n=4; data not shown). We also
tested the effects of Lig and DH-Lig on mouseTRPM8.
None of the compounds could activated this channel (n=6).
However, if TRPM8 was activated by menthol, application
of both compounds caused a potent inhibition (100 μM
menthol, +80 mV block of 88±6% and 89.8±3% for 300 μM
Lig and DH-Lig, respectively; data not shown, n=4).
Discussion
Ligustilide is a plant product of dietary and medicinal
relevance, and its biological profile has been extensively
investigated in cellular and animal models of disease [4, 6,
13, 21, 24, 25, 27], but very little is known on its biological
targets and the molecular mechanism(s) underlying its
activity. Despite its structural simplicity, Lig has a complex
cross-conjugated di-unsaturated system. It shows Michael-
acceptor properties, reacting with thiols to give a mixture of
adducts that easily revert to the starting unsaturated
compound [20], and has been reported to induce cellular
anti-oxidant responses due to by activation of the transcrip-
tion factor Nrf2 by covalent alkylation [5]. Michael
acceptors like α,β-unsaturated carbonyls are believed to
activate TRPA1 by exploiting the high reactivity of certain
cysteine residues, and two recent reports have indeed
provided compelling evidence that activation of TRPA1
by several agonists, including cinnamaldehyde, acrolein
and MO, occurs through covalent modification of N-
terminal cysteine residues on the channel [14, 22]. The
“activate” status for a cysteine residue originates from its
location in a molecular environment capable to provide
electrophilic activation of the carbonyl oxygen of a Michael
acceptor, an increased acidity of the thiol group, or a
combination of both [19]. The alkylation reaction requires
therefore a precise spatial relationship between the carbonyl
activating element and the reactive cysteine thiol group
[19]. Compared to other Michael acceptors that activate
TRPA1, Lig and DH-Lig, are characterized by a more
extended unsaturated system, which spans a double bond in
Lig, and a phenyl group in DH-Lig. It was therefore
interesting to investigate if they could still act as covalent
activators of TRPA1, and, if so, to compare their profile
with that of MO, a classic covalent activator.
Surprisingly, Lig and DH-Lig showed a complementary
pattern of interaction with TRPA1. Thus, while Lig was a
potent activator, with only marginal inhibitory properties on
MO-induced activation, DH-Lig could potently inhibit MO-
Fig. 4 Cross-desensitization between MO and ligustilide/dehydroli-
gustilide. Note solutions with an extracellular Ca2+ concentration of
1.5 mM were used in the experiments to accelerate TRPA1
inactivation. a Representative time course of whole-cell currents
elicited by 100 μM MO, applied after the washout of 300 μM Lig
stimulation on TRPA1. Shown are the currents obtained from voltage
ramps at −80 mV (black circles) and +80 mV (red circles). b Time
course of whole-cell currents induced by 100 μM MO, without
subsequent stimulation by Lig measured at membrane potential
of −80 mV (black circles) and +80 mV (red circles). c Representative
time course of whole-cell currents elicited by 300 μM DH-lig showed
a smaller but transient activation of TRPA1, followed by a dramatic
rebound effect after washing out of DH-Lig and no subsequent
activation by 100 μM MO. Shown are the currents obtained from
voltage ramps at −80 mV (black circles) and +80 mV (red circles). d
Time course of whole-cell currents activated by 100 μM MO
prevented a secondary stimulation by 300 μM DH-Lig, but followed
with an inhibition of DH-Lig. Shown are the currents measured at
membrane potential of −80 mV (black circles) and +80 mV (red
circles)
846 Pflugers Arch - Eur J Physiol (2011) 462:841–849
induced activation of TRPA1, with only modest activating
capacity. The study of TRPA1 mutants characterized by the
replacement of the active cysteine residues with serine,
evidenced that Lig did not substantially deviate from the
activation profile of MO, while, unexpectedly, DH-Lig
interacted with TRPA1 in an essentially non-covalent
Fig. 5 Differential effects of ligustilide and dehydroligustilide on
whole cell currents through C622/642S mutant TRPA1. a Represen-
tative time course of whole-cell currents elicited by Lig and MO at
indicated concentrations through C622/642S mutant TRPA1 measured
at membrane potential of −80 mV (black circles) and +80 mV (red
circles). b I–V relations measured at the times indicated in a. c Average
values for increased currents activated by 300 μM Lig and 100 μM
MO through both wild-type and C622/642S mutant TRPA1. d
Representative time course of whole-cell currents induced by DH-
Lig and MO at indicated concentrations through C622/642S mutant
TRPA1 measured at membrane potential of −80 mV (black circles)
and +80 mV (red circles). e I–V relations measured at the times
indicated in d. f Average values for increased currents activated by
300 μM DH-Lig and 100 μM MO through both wild-type and C622/
642S mutant TRPA1
Fig. 6 Differential effects of
ligustilide and dehydroligusti-
lide on whole cell currents
through C622S and C622/642/
666S mutant TRPA1. a Average
values for increased currents
activated by 300 μM Lig and
100 μM MO through wild type,
C622S and C622/642/666S
mutant TRPA1. b Average
values for increased currents
activated by 300 μM DH-Lig
and 100 μM MO through wild
type, C622S and C622/642/
666S mutant TRPA1
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fashion. When subjected to an NMR assay for in situ
reaction with cysteamine, an in vitro mimic of the in vivo
reaction with an active cysteine residue [2], neither Lig nor
DH-Lig showed any reaction. The lack of reaction of DH-
Lig is in accordance with observations done for its
interaction with TRPA1, which is essentially non-covalent,
while the failure of Lig to give a positive assay is in
contrast with the results observed with TRPA1 and Nrf2
[5], which show a Michael-type reactivity in cell systems.
This discrepancy might be due either to a limitation of the
NMR method, that is unable to detect the Michael reactivity
of extended electrophilic systems, or to the complexity of
the electronic system of Lig, that, after the initial 1,6-
addition at the distal carbon of the unsaturated system, can
also add a second thiol group in the usual 1,4-fashion [3]. It
is therefore not unconceivable to assume that, within the
cysteine rich ankyrin loop of TRPA1, Lig is “activated” in
situ by a reversible 1,6-addition, generating a more reactive
α,β-unsaturated system that is the actual alkylating agent.
Our observation, while qualifying the phthalide element
as a privileged structure to modulate the activity of TRPA1,
also raises some interesting issues. First, it is not clear to
what extent the Lig-sensitive activating site and the DH-
Lig-sensitive inhibitory site overlap in TRPA1. The reversal
of profile observed for the dehydrogenation of Lig to DH-
Lig pair is reminiscent of the one associated to the
iodination of RTX or capsaicin, with iodination being
capable of reversing the activity at TRPV1 level [1]. Next,
as a covalent activator of anti-oxidant response via Nrf2 [5]
and of TRPA1-associated sensory responses, Lig seems to
basically act as a biological analogue of MO, despite the
very different profile of in vivo activities associated to both
compounds. On the other hand, the diverse structure of the
two compounds and their chemical reactivity might
translate into a different pharmacokinetic profile and tissue
distribution, diversifying what seems a basically over-
lapping pharmacodynamic profile [26]. Finally, the broad
tuning of TRPA1 and its sensitivity to dietary constituents
suggest a certain complementarity to the bitter-sensing system
[16], with TRPA1 aimed at sensing electrophilic and oxidant
compounds and the bitter receptors at sensing alkaloids,
providing us with a sensory shield towards the two most
common classes of environmental and dietary toxins.
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